XML 62 R59.htm IDEA: XBRL DOCUMENT v3.19.3

Geneos Therapeutics, Inc. (Details) $ in Thousands	1 Months Ended
	Feb. 28, 2019 USD ($)
Geneos Therapeutics, Inc.
Noncontrolling Interest [Line Items]
Sale of stock, consideration received	$ 4,500
Geneos Therapeutics, Inc.
Noncontrolling Interest [Line Items]
Payments to acquire additional interest in subsidiaries	1,200
Stock purchase agreement, commitment of additional investment	800
Stock purchase agreement, commitment of additional investment upon milestone	$ 800
Noncontrolling interest, ownership percentage by parent	61.00%

X

- Definition

Stock Purchase Agreement, Commitment Of Additional Investment

+ References

No definition available.

+ Details

Name:	ino_StockPurchaseAgreementCommitmentOfAdditionalInvestment
Namespace Prefix:	ino_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Stock Purchase Agreement, Commitment Of Additional Investment Upon Milestone

+ References

No definition available.

+ Details

Name:	ino_StockPurchaseAgreementCommitmentOfAdditionalInvestmentUponMilestone
Namespace Prefix:	ino_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The parent entity's interest in net assets of the subsidiary, expressed as a percentage.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The cash outflow associated with the purchase of noncontrolling interest during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Cash received on stock transaction after deduction of issuance costs.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	dei_LegalEntityAxis=ino_GeneosTherapeuticsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_OwnershipAxis=ino_GeneosTherapeuticsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: